Pfizer nabs $13.5B in U.S. bond issue

No one can accuse Pfizer leadership of timidity. With the nation mired in a deep recession, the company Tuesday launched the second largest U.S.-dollar bond issue in history, a $13.5 billion offering to help fund its $68 billion acquisition of Wyeth. (It's exceeded only by Roche's recent $16 billion for its Genentech buy.) Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.